MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
about
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transitionMucin-based targeted pancreatic cancer therapyMolecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.A tumor specific antibody to aid breast cancer screening in women with dense breast tissueMUC1: a multifaceted oncoprotein with a key role in cancer progression.Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancerDevelopment of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infectionMUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Genetically engineered mucin mouse models for inflammation and cancer.MUC1 regulates PDGFA expression during pancreatic cancer progressionSigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.Genetically engineered mouse models of pancreatic cancer.Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancerMUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesOncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrowIntratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisThe use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Immunobiology of human mucin 1 in a preclinical ovarian tumor model.Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population.MUC1 immunotherapy.Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.Mucins in pancreatic cancer and its microenvironment.Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Mucins and pancreatic cancer.The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.
P2860
Q24632480-F3034575-3D32-4597-A0C8-B43FA72EEAC8Q26861761-34E62ACC-3184-4BB4-8A21-67089BA451E1Q33624574-6784A8FF-CC5D-40F8-B0A7-835F24898330Q33849311-820F87E6-2926-40AF-8308-FEEEFC7461E4Q33849708-C6FB5524-6418-411F-97DA-8426B7E68A6FQ33880143-99F163F7-229D-45DE-8F01-6B98350AFE7EQ34000467-B4865EBA-11BB-4636-9FD6-6F76DCB9BD7BQ34898405-BFC4B5EF-CD3C-4D8C-811B-C888F2757607Q35035389-FBBB3408-410F-4F54-BFCC-77577220A7A8Q35605048-06CCC3CC-8F7C-413C-9FA7-EE27653AD2D7Q35749993-D4909732-49D2-45BE-B983-00F627D654BDQ35846935-8842DA10-A3F0-4716-A396-07AE1EB76024Q35870682-6730543F-0471-4516-A306-CF6376537BA0Q35904634-7FF5764B-80D3-4F77-B313-2AA0C9BBB02DQ35916552-3F6DF61D-FFBD-47C0-9C0C-4C581404F389Q36249357-7DA470F5-AB47-4BC1-B5A2-6885D7F49363Q36249508-2DECCEC4-1B8F-4351-AA5D-449B383DB653Q36437150-C1F25250-552E-420D-974F-B0831E7A5C11Q36675786-5C18F455-2E75-4DBD-AE35-2B6CD06F1E75Q37047682-0BB5CFB7-9D0F-49E4-9530-AC1ED069508AQ37087112-25D712B7-62BC-45C9-9265-A1CFC15CB274Q37123143-91895C6C-4318-4771-95C2-F8F4CF099FCBQ37124065-B4C99D34-9BEF-4A5F-8DB6-CF1E544BBC09Q37249025-E4D9C80F-10F1-4A97-824E-C11016E2F1C3Q37322304-7CC9ACE8-31BF-4B5A-BC0F-5720A3C3FBC9Q37338140-5BA4024F-43D8-4147-8634-75B3B62AC476Q37376094-7D7B639F-50A5-4888-A7DB-9F744FB4F616Q37381597-C2232971-AFDF-4416-B832-AB78DC97EDB4Q37411831-3164B6DA-A5A2-4EFF-8DEE-A406FDE18E8DQ37434103-9982B5B9-9229-478C-9725-756D544C93E7Q37522460-1FEDE42A-BCFB-41A0-951C-2B23E08B8BFCQ37527861-D0369ECA-D6C5-40B8-B6FE-ACA12F838DADQ37598872-C4B54B80-5378-4480-A8DA-4CFF8006434DQ37773241-A98E836A-5B6A-43D6-AD71-0D78EEB029AFQ38097532-95F25DA2-B3C1-4645-A68E-EB805C9A7C2CQ38121746-CBF04DE5-C0A3-4BDE-8F01-032082702F4EQ38142315-0B47622A-96C8-446C-8452-8D2C1DD83705Q38162151-F7D4B413-541D-422E-BB94-75343C69001BQ38166583-078621F8-9157-4CC4-8488-BC3CC5FB5C50Q38181143-C682FFEA-5B08-45C8-BDE3-759E96F696F4
P2860
MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@en
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@nl
type
label
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@en
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@nl
prefLabel
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@en
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@nl
P2093
P2860
P1476
MUC1 enhances tumor progressio ...... ous pancreatic adenocarcinoma.
@en
P2093
Arefayene Million
Durai B Subramani
Gargi D Basu
Jorge Schettini
Judy M Bradley
Pinku Mukherjee
Teresa L Tinder
Todd Skaar
P2860
P304
P356
10.4049/JIMMUNOL.181.5.3116
P407
P577
2008-09-01T00:00:00Z